MM
Marianna Mancini
Chief Operating Officer

Marianna Mancini insider trades: Viking Therapeutics (VKTX) stock sales

Chief Operating Officer, Viking Therapeutics Last trade Jul 29, 2026 20 Form 4 filings
$2.5M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Marianna reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 29, 2026VKTX↓ Sell$610K
Jan 5, 2026VKTX↓ Sell$1.9M
Oct 28, 2025VKTX↓ Sell$216K
Jul 3, 2025VKTX↓ Sell$118K
Jan 6, 2025VKTX↓ Sell$2.3M
Jul 30, 2024VKTX↓ Sell$1.0M
May 1, 2024VKTX↓ Sell$22.1M
Apr 17, 2023VKTX↓ Sell$250K
Mar 29, 2023VKTX↓ Sell$3.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VKTX insiders

Open-market trades in the last 12 months

About Marianna Mancini's insider trades

Marianna Mancini is Chief Operating Officer at Viking Therapeutics (VKTX). Since Mar 29, 2023, Marianna has reported no open-market purchases and 9 sales worth $32.2M on SEC Form 4. In the last 12 months: 2 sales ($2.5M).

Their filings also include grants and awards (14 filings), shares withheld for taxes (11 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VKTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.